ARMEN GARO H 4
4 · AGENUS INC · Filed May 19, 2026
Research Summary
AI-generated summary of this filing
Agenus (AGEN) CEO Garo H. Armen Receives Stock Award
What Happened
Garo H. Armen, Chairman, Chief Executive Officer and Principal Financial Officer of Agenus Inc. (AGEN), received 4,540 shares of common stock on May 15, 2026 as salary paid in stock. The filing values the issuance at $3.58 per share for a total of $16,253. This was an award/acquisition issued under the company’s 2019 Equity Incentive plan and the shares were fully vested on issuance.
Key Details
- Transaction date: May 15, 2026; Filing date: May 19, 2026 (filed within required reporting window).
- Price used for valuation: $3.58 per share (closing price on May 15, 2026).
- Shares issued: 4,540; total value reported: $16,253.
- Shares were issued as salary in lieu of cash (net amount for the pay period ending May 15, 2026).
- Shares are held in Dr. Armen’s IRA accounts per the filing.
- The filing does not state the total number of Agenus shares Dr. Armen beneficially owns after this issuance.
- Notable ownership disclosures: Dr. Armen is trustee and has investment authority for the Garo Armen 2020 2 Year AG GRAT holding 23,950 shares and is a general partner in Pixie Partners (which owns 5,000 shares); he disclaims beneficial ownership to the extent of his pecuniary interest in Pixie.
Context
This was a compensation issuance (salary paid in stock), not an open-market buy or sale. Such awards reflect how an insider is being paid rather than a direct signal of personal buying/selling intent. The shares were fully vested at issuance and are held in IRA accounts; reporting was timely.
Insider Transaction Report
- Award
Common Stock
[F1][F2]2026-05-15$3.58/sh+4,540$16,253→ 351,323 total
- 31,298(indirect: See Footnote)
Common Stock
[F3] - 28,950(indirect: See Footnote)
Common Stock
[F4]
Footnotes (4)
- [F1]At his request and with the approval of the Agenus Inc. Compensation Committee, Garo H. Armen's salary is being paid in stock, in lieu of cash. The amount reported herein represents the net amount of Dr. Armen's salary for the pay period ending May 15, 2026. Such shares are issued in accordance with the Amended and Restated Agenus Inc. 2019 Equity Incentive are fully vested on the date of issuance.
- [F2]$3.58 is the closing price of our Common Stock on May 15, 2026, the last trading day for the payroll date for the pay period ending May 15, 2026.
- [F3]Shares are held in Dr. Armen's IRA accounts.
- [F4]Dr. Armen is trustee and has investment authority for the Garo Armen 2020 2 Year AG GRAT holder of 23,950 shares of our Common Stock. Dr. Armen is a general partner in Pixie Partners, a General Partnership ("Pixie"), which as of the date of this report owns 5,000 shares of our Common Stock. Dr. Armen has a pecuniary interest in only a portion of the shares held by Pixie and disclaims beneficial ownership to the extent of his pecuniary interest therein.